News View all news
Evotec invests into Oxford Cell Therapy Company "OxVax"
Hamburg, Germany, 21 Apr 2021
Evotec SE announced today that the Company has invested into OxVax, a new immuno-oncology company based on research from Oxford...Read more
Investor Relations Events View all events
Kempen Life Sciences Conference
Quarterly Statement Q1 2021 and webcast